The Songjiang Institute of Shanghai Jiao Tong University School of Medicine (hereinafter referred to as the Institute) was officially established on July 28, 2022. It is a research institution jointly built by the People's Government of Songjiang District, Shanghai and Shanghai Jiao Tong University School of Medicine. The research institute has been vigorously promoting institutional and mechanism innovation. Relying on the research advantages of the "Brain Science Research Alliance" of Shanghai Jiao Tong University School of Medicine in the fields of brain function and brain diseases, it has taken the opportunity of undertaking the major project of National Science and Technology Innovation 2030- "Brain Science and Brain-like Research" and jointly building the Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (hereinafter referred to as Songjiang Hospital). Align with the "Double First-Class" construction of Shanghai Jiao Tong University School of Medicine and the "Big Health" strategy of the main campus of Shanghai Jiao Tong University; We will constantly improve the cross-disciplinary, cross-departmental and cross-industry cross-disciplinary system and mechanism, effectively promote the integration of medicine and engineering, as well as the deep integration of brain science with advantageous disciplines such as basic medicine and clinical medicine, build a "talent chain, innovation chain and industrial chain", assist Songjiang Hospital in achieving high-quality development, enhance the level and quality of regional medical services, and provide strong support for the construction of "Healthy Songjiang".

Adhering to the concept that "talent is the primary resource and innovation is the primary driving force", the research institute has gathered a group of high-level talents with an international perspective. Currently, it has recruited 23 outstanding PIs from home and abroad to take up their posts and carry out research work. The research institute, in collaboration with the high-quality resources of the biomedicine and brain-intelligence science and technology innovation industrial clusters along the G60 Science and Technology Innovation Corridor, focuses on the "three brains" (developmental brain, mental brain, and degenerative brain), and combines emerging brain-cross-disciplinary directions such as neuroimmunity, neurometabolism, and neurooncology. In the future, it will build a 30,000-square-meter "basic - clinical - industrial" full-chain scientific research platform. Committed to fostering the output of major innovative, original and disruptive basic research achievements, achieving significant breakthroughs in key technologies of original innovation, cultivating a group of brain science professionals with innovative thinking and international influence in the fields of industry, academia and research, and contributing to the high-quality development of Shanghai's biomedicine and artificial intelligence industries Support the construction of "Healthy Shanghai" and even "Healthy China", as well as the G60 Science and Technology Innovation Center with global influence, become the source of brain science research and development in China, and a new engine for the economic and social development of Songjiang District.

The PI who joined Songjiang Research Institute has published a series of papers in top international journals in the past three years, including more than thirty papers such as Science, Cell, Nature Neuroscience, Cell Stem Cell, Neuron, etc.